In December 1998, Novoste recorded its first commercial sale of the Beta-Cath TM System. Pharmasset, Inc. is awholly-owned subsidiary of Pharmasset, Ltd., a Barbados International Business Corporation. Pharmasset has successfully garnered initial and mezzanine equity financing. Virtually Better, established in 1996, develops, tests, and markets the Virtually Better systems of virtual reality exposure therapy in the treatment of anxiety disorders such as phobias, fear of heights, and post-traumatic stress disorders. Dr. Larry hodges.
Patients use headsets and video to recreate their phobia.
Virtually Better is envisioned to be centered primarily on the development, support, and sale of software for the Birtually Better systems of virtual reality exposure therapy. Dr. Langberg and two colleagues, his counterpart at UCSF, Dr. Michael Lesh, and Dr. Michael Ross, adjunct professor in the Radiology Department of Stanford. Atrionix mission is to develop diagnostic systems that improve treatment for patients with the impaired heart rhythm called atrial fibrillation. Additionally, the company is designing a nonsurgical technology that uses a catheter to cure severe cases of this disorder. Human clinical trials for this procedure will begin next year.